This inventor holds 5 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignees: National Health Research Institutes, National Taiwan University, National Yang Ming Chiao Tung University. Active years: 2018-2025.
Company Filing History:
5 out of 188 
5 out of 1,390 
5 out of 1,243 Years Active: 2018-2025
Title: Innovations of Yu-Li Liu
Introduction
Yu-Li Liu is a notable inventor based in Miaoli, Taiwan. He has made significant contributions to the field of neurological disorders through his innovative work. With a total of 5 patents, Liu has established himself as a key figure in his area of expertise.
Latest Patents
One of his latest patents includes the development of substituted benzimidazole derivatives as D-amino acid oxidase (DAAO) inhibitors. This invention provides novel compounds that can be utilized for the treatment and/or prevention of neurological disorders. The focus on DAAO inhibitors highlights Liu's commitment to addressing critical health issues.
Career Highlights
Throughout his career, Yu-Li Liu has worked with various institutions, including National Taiwan University. His research and innovations have garnered attention and respect within the scientific community. Liu's work is characterized by a dedication to advancing medical science and improving patient outcomes.
Collaborations
Some of his notable coworkers include Yufeng Jane Tseng and Chung-Ming Sun. Their collaborative efforts have contributed to the success of Liu's projects and innovations.
Conclusion
Yu-Li Liu's contributions to the field of neurological disorders through his innovative patents demonstrate his expertise and commitment to improving health outcomes. His work continues to inspire future research and development in this critical area.